Celgene Corporation (CELG) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
86 MORRIS AVENUE SUMMIT, NJ 07901 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 9/30/2019 MRQ | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 4,730 | 12,042 | 7,970 | 6,552 | 7,547 | 5,687 | |||
| Cash and cash equivalents | 4,234 | 7,013 | 6,170 | 4,880 | 4,122 | 3,234 | |||
| Short-term investments | 496 | 5,029 | 1,800 | 1,672 | 3,425 | 2,453 | |||
| Receivables | 2,066 | 1,921 | 1,621 | 1,421 | 1,167 | 1,061 | |||
| Inventory, net of allowances, customer advances and progress billings | 458 | 541 | 498 | 443 | 393 | 340 | |||
| Inventory | 458 | 541 | 498 | 443 | 393 | 340 | |||
| Other current assets | 501 | 388 | 779 | 985 | 594 | 436 | |||
| Other undisclosed current assets | 1,312 | 12 | 25 | ||||||
| Total current assets: | 9,067 | 14,892 | 10,868 | 9,401 | 9,713 | 7,551 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 1,367 | 1,070 | 930 | 814 | 643 | 593 | |||
| Intangible assets, net (including goodwill) | 24,216 | 13,302 | 15,258 | 15,737 | 6,259 | 4,881 | |||
| Goodwill | 8,003 | 4,866 | 4,866 | 4,879 | 2,191 | 2,041 | |||
| Intangible assets, net (excluding goodwill) | 16,213 | 8,436 | 10,392 | 10,858 | 4,068 | 2,840 | |||
| Other noncurrent assets | 830 | 877 | 1,031 | 1,101 | 726 | 353 | |||
| Total noncurrent assets: | 26,413 | 15,249 | 17,218 | 17,653 | 7,628 | 5,828 | |||
| TOTAL ASSETS: | 35,480 | 30,141 | 28,086 | 27,053 | 17,340 | 13,378 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 2,987 | 2,523 | 2,115 | 1,618 | 1,484 | 1,427 | |||
| Taxes payable | 9 | 8 | |||||||
| Employee-related liabilities | 285 | 262 | |||||||
| Accounts payable | 418 | 305 | 247 | 241 | 198 | 156 | |||
| Accrued liabilities | 2,987 | 2,523 | 2,115 | 1,377 | 991 | 1,001 | |||
| Other undisclosed accounts payable and accrued liabilities | (418) | (305) | (247) | ||||||
| Debt | 501 | 35 | 501 | 606 | 545 | ||||
| Derivative instruments and hedges, liabilities | 5 | 3 | 56 | ||||||
| Estimated litigation liability | 199 | ||||||||
| Other liabilities | 271 | 276 | 200 | ||||||
| Deferred revenue and credits | ✕ | ✕ | 75 | 55 | 61 | 29 | 28 | ||
| Deferred tax liabilities | ✕ | 131 | |||||||
| Contract with customer, liability | ✕ | 73 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other undisclosed current liabilities | 496 | 354 | 90 | 15 | (416) | (309) | |||
| Total current liabilities: | 4,057 | 2,987 | 2,959 | 1,969 | 2,112 | 1,946 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 19,769 | 15,838 | 13,789 | 14,250 | 6,266 | 14 | |||
| Long-term debt, excluding current maturities | 19,769 | 15,838 | 13,789 | 14,250 | 6,266 | 14 | |||
| Liabilities, other than long-term debt | 5,493 | 4,395 | 2,219 | 3,322 | 2,623 | 1,802 | |||
| Deferred revenue and credits | ✕ | ✕ | 34 | 28 | 30 | 59 | 52 | ||
| Accounts payable and accrued liabilities | 2,190 | 2,490 | 420 | 324 | |||||
| Accrued income taxes | ✕ | ✕ | ✕ | ✕ | ✕ | 273 | 235 | ||
| Contract with customer, liability | ✕ | 73 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Deferred compensation liability, classified | 171 | 151 | 127 | ||||||
| Deferred tax liabilities, net | ✕ | 2,753 | 1,327 | 378 | 556 | 805 | |||
| Other liabilities | 477 | 544 | 1,771 | 2,042 | 1,581 | 583 | |||
| Derivative instruments and hedges, liabilities | 378 | 4 | |||||||
| Other undisclosed noncurrent liabilities | 2,519 | 1,593 | (186) | 4,027 | |||||
| Total noncurrent liabilities: | 25,262 | 20,233 | 18,527 | 19,166 | 8,703 | 5,843 | |||
| Total liabilities: | 29,319 | 23,220 | 21,486 | 21,134 | 10,815 | 7,788 | |||
| Equity | |||||||||
| Equity, attributable to parent | 6,161 | 6,921 | 6,599 | 5,919 | 6,525 | 5,590 | |||
| Common stock | 10 | 10 | 10 | 9 | 9 | 5 | |||
| Treasury stock, value | (26,336) | (20,243) | (16,281) | (14,052) | (10,699) | (7,662) | |||
| Additional paid in capital | 14,978 | 13,806 | 12,378 | 11,119 | 9,827 | 8,680 | |||
| Accumulated other comprehensive income (loss) | (50) | 287 | 419 | 768 | 915 | 94 | |||
| Retained earnings | 17,559 | 13,061 | 10,074 | 8,074 | 6,472 | 4,473 | |||
| Other undisclosed equity | (6,211) | (6,634) | (6,180) | ||||||
| Total equity: | (50) | 287 | 419 | 5,919 | 6,525 | 5,590 | |||
| Other undisclosed liabilities and equity | 6,211 | 6,634 | 6,180 | ||||||
| TOTAL LIABILITIES AND EQUITY: | 35,480 | 30,141 | 28,086 | 27,053 | 17,340 | 13,378 | |||
Income Statement (P&L) ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 15,281 | 13,003 | 11,229 | 9,256 | 7,670 | 6,494 | ||
| Revenue, net | ✕ | ✕ | 13,003 | 11,229 | 9,256 | 7,670 | 6,494 | |
| Cost of revenue | (1,055) | (790) | (897) | (699) | (386) | (340) | ||
| Cost of goods and services sold | (587) | (461) | (438) | (420) | (386) | (340) | ||
| Other undisclosed gross profit | 452 | 299 | 414 | 184 | (107) | (132) | ||
| Gross profit: | 14,678 | 12,512 | 10,747 | 8,741 | 7,178 | 6,022 | ||
| Operating expenses | (9,035) | (7,506) | (7,166) | (6,302) | (4,904) | (4,464) | ||
| Other undisclosed operating income (loss) | (452) | (299) | (414) | (184) | 245 | 251 | ||
| Operating income: | 5,191 | 4,707 | 3,167 | 2,255 | 2,519 | 1,809 | ||
| Nonoperating income (expense) | 382 | 105 | (294) | 80 | (25) | (74) | ||
| Investment income, nonoperating | 45 | 105 | 30 | 31 | 28 | 22 | ||
| Loss, foreign currency transaction, before tax | (10) | (22) | ||||||
| Other nonoperating income (expense) | 337 | (324) | 48 | (44) | (74) | |||
| Interest and debt expense | (741) | (500) | (311) | (176) | (92) | |||
| Income from continuing operations before equity method investments, income taxes: | 4,832 | 4,812 | 2,373 | 2,024 | 2,318 | 1,643 | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (498) | 10 | 22 | |||||
| Income from continuing operations before income taxes: | 4,832 | 4,314 | 2,373 | 2,024 | 2,327 | 1,665 | ||
| Income tax expense | (786) | (1,374) | (373) | (422) | (328) | (216) | ||
| Income from continuing operations: | 4,046 | 2,940 | 1,999 | 1,602 | 2,000 | 1,450 | ||
| Income before gain (loss) on sale of properties: | 4,046 | 2,940 | 1,999 | 1,602 | 2,000 | 1,450 | ||
| Net income available to common stockholders, diluted: | 4,046 | 2,940 | 1,999 | 1,602 | 2,000 | 1,450 | ||
Comprehensive Income ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 4,046 | 2,940 | 1,999 | 1,602 | 2,000 | 1,450 | ||
| Other comprehensive income (loss) | 233 | (102) | (349) | (147) | 821 | 144 | ||
| Comprehensive income, net of tax, attributable to parent: | 4,279 | 2,838 | 1,651 | 1,455 | 2,821 | 1,594 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.